Takotsubo Cardiomyopathy in an Alzheimer Disease Patient: The Potential Contribution of Antidepressant Agents

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):360-361. doi: 10.1097/WAD.0000000000000395.

Abstract

Takotsubo cardiomyopathy (TC) is an acute cardiac dysfunction, clinically similar to myocardial ischemia. The physiopathology of the syndrome seems to be related to excessive sympathetic activity that is triggered by physical or emotional stress factors. We report the case of an 83-year-old woman with advanced Alzheimer disease who had recently used nortriptyline and sertraline and was admitted with chest pain. An electrocardiogram showed ST-elevation, and markers of myocardial necrosis were slightly increased. However, coronariography did not demonstrate stenotic lesions. Transthoracic echocardiography and ventriculography identified decreased ventricular function, apical akinesia, and compensatory hyperkinesia of other segments that were compatible with TC. The patient evolved with cardiogenic shock and died. Alzheimer patients may be more susceptible to develop TC, both because of the disease itself and because of the multiple medications they are exposed to that increase catecholamine levels. In this case, antidepressant drugs were considered to be a potential factor that enhanced the susceptibility.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease* / complications
  • Alzheimer Disease* / drug therapy
  • Antidepressive Agents / therapeutic use*
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Chest Pain / etiology
  • Echocardiography
  • Electrocardiography
  • Fatal Outcome
  • Female
  • Humans
  • Nortriptyline / therapeutic use*
  • Sertraline / therapeutic use*
  • Takotsubo Cardiomyopathy* / etiology
  • Takotsubo Cardiomyopathy* / physiopathology

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
  • Nortriptyline
  • Sertraline